YTE reported $30.48M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Cti Biopharma CTIC:US USD 108.09M 715K
Eli Lilly And LLY:US USD 14.14B 548.2M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Moderna Inc MRNA:US USD 922M 281M
Novartis NOVN:VX USD 21.24B 2.55B
Novartis NVS:US USD 21.24B 2.55B
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K